Fundraising FoxEMBL Ventures
Venture capitalHeidelberg · Seed–Series A · 2 people tracked
Find your way into EMBL Ventures
Sign up to see every warm intro you have to EMBL Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the EMBL Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
EMBL Ventures invests in life science companies throughout Europe, aiming to build businesses with significant commercial potential in areas such as new therapeutic treatment modalities and pharmaceuticals, next-generation enabling technology platforms, and innovations in diagnostics and medical devices. The firm draws on a strong scientific and life science industry network, an established investment track record, and experience building companies, structuring collaboration and licensing agreements, and executing M&A and IPOs. Portfolio companies receive hands-on support, access to the firm's network, and unique access to the EMBL, which the firm views as a source of added value.
Source: firm website, verified Aug 3, 2026.
Team · 2 people
from curated & public directories
What they invest in
from 3 of 10 portfolio companiesBiotech ×3Healthtech ×2Medical Devices ×1
HQs:Germany×1United States×1
Investments · 10 tracked
founders shown can be your intro path
Topas Therapeutics develops nanoparticle-based therapies to induce immune tolerance for autoimmune and immune-mediated diseases.
BiotechHealthtech
Hugo Fry(Chief Executive Officer)inChristian Schröter(Chief Operating Officer)Cristina de Min(Chief Medical Officer)Anne Burger(Chief Financial Officer)Alex Marshall(Chief Business Officer)in
Co-investorsGimvBoehringer Ingelheim Venture FundBioMedPartnersEpidarex Capital
Antibiotic developer, maker of cefepime/enmetazobactam (EXBLIFEP).
Co-investorsAndera PartnersBioMedPartnersDelos CapitalXeraya CapitalForbion
NASDAQ-listed company developing therapies for complement cascade-driven diseases in haematology, ophthalmology, and nephrology.
BiotechCrestwood, US
Pascal Deschatelets(Executive Officer)inCedric Francois(Executive Officer, Director)in
BoardGerald Chan(Director)Stephanie O'Brien(Director)Alec Machiels(Director)A. Sinclair Dunlop(Director)
Co-investorsAvoro Capital AdvisorsEpidarex CapitalF-Prime CapitalKeyhorse CapitalSofinnova VenturesSolasta Ventures+1 more
Crescendo Biologics develops novel immune cell-enhancing therapeutics for immuno-oncology using its patent-protected Humabody VH platform, a fully human domain technology clinically validated in oncology and immunology.
BiotechHealthtechMedical Devices
Co-investorsAndera PartnersQuan CapitalSofinnova PartnersAstellas Venture Management LLCFuture Planet CapitalAvlar BioVentures+3 more
MIG portfolio company taken public.
Harpreet Singh(Founder)in
Co-investorsGrazia Equity GmbHLSG HoldingsMIG Capital AG
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AmphivenaArsanisLuxendoOpsona TherapeuticsViraTherapeutics
Exits · 3
3 acquisitionsApellis Pharmaceuticalsacq. by BiogenLuxendoacq. by BrukerViraTherapeuticsacq. by Boehringer Ingelheim
Portfolio news
latest coverage across their companies
Immatics · stocktitan.net · Aug 25, 2026
Frequently asked questions
- How many investments has EMBL Ventures made?
- EMBL Ventures has 10 tracked investments, 3 of which have exited.
- What stage does EMBL Ventures invest at?
- EMBL Ventures invests at the Seed, Series A stages.
- What is EMBL Ventures's typical check size?
- EMBL Ventures typically writes checks of $108K – $5.4M.
- What sectors does EMBL Ventures focus on?
- EMBL Ventures focuses on Biotech, Deep Tech, Healthtech, Medical Devices.
- Where is EMBL Ventures located?
- EMBL Ventures is headquartered in Heidelberg, DE.
- Who does EMBL Ventures co-invest with?
- EMBL Ventures most often shares deals with Andera Partners, BioMedPartners, Epidarex Capital, among 19 tracked co-investors.
Images
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.